The Role of SCAP/SREBP as Central Regulators of Lipid Metabolism in Hepatic Steatosis
Top Cited Papers
Open Access
- 16 January 2024
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (2) , 1109
Abstract
The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) is rapidly increasing worldwide at an alarming pace, due to an increase in obesity, sedentary and unhealthy lifestyles, and unbalanced dietary habits. MASLD is a unique, multi-factorial condition with several phases of progression including steatosis, steatohepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma. Sterol element binding protein 1c (SREBP1c) is the main transcription factor involved in regulating hepatic de novo lipogenesis. This transcription factor is synthesized as an inactive precursor, and its proteolytic maturation is initiated in the membrane of the endoplasmic reticulum upon stimulation by insulin. SREBP cleavage activating protein (SCAP) is required as a chaperon protein to escort SREBP from the endoplasmic reticulum and to facilitate the proteolytic release of the N-terminal domain of SREBP into the Golgi. SCAP inhibition prevents activation of SREBP and inhibits the expression of genes involved in triglyceride and fatty acid synthesis, resulting in the inhibition of de novo lipogenesis. In line, previous studies have shown that SCAP inhibition can resolve hepatic steatosis in animal models and intensive research is going on to understand the effects of SCAP in the pathogenesis of human disease. This review focuses on the versatile roles of SCAP/SREBP regulation in de novo lipogenesis and the structure and molecular features of SCAP/SREBP in the progression of hepatic steatosis. In addition, recent studies that attempt to target the SCAP/SREBP axis as a therapeutic option to interfere with MASLD are discussed.Keywords
Funding Information
- German Research Foundation (WE2554/13-1, WE2554/15-1, WE 2554/17-1, 70115581, PTD 1-5)
- Deutsche Krebshilfe (WE2554/13-1, WE2554/15-1, WE 2554/17-1, 70115581, PTD 1-5)
- Interdisciplinary Centre for Clinical Research within the faculty of Medicine at the RWTH Aachen University (WE2554/13-1, WE2554/15-1, WE 2554/17-1, 70115581, PTD 1-5)
This publication has 94 references indexed in Scilit:
- A pathway approach to investigate the function and regulation of SREBPsGenes & Nutrition, 2013
- SREBPs: metabolic integrators in physiology and metabolismTrends in Endocrinology & Metabolism, 2012
- The Scap/SREBP Pathway Is Essential for Developing Diabetic Fatty Liver and Carbohydrate-Induced Hypertriglyceridemia in AnimalsCell Metabolism, 2012
- mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP PathwayCell, 2011
- microRNAs and cholesterol metabolismTrends in Endocrinology & Metabolism, 2010
- Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1Molecular Cell, 2010
- Polyunsaturated Fatty Acids Selectively Suppress Sterol Regulatory Element-binding Protein-1 through Proteolytic Processing and Autoloop Regulatory CircuitJournal of Biological Chemistry, 2010
- Insulin Enhances the Biogenesis of Nuclear Sterol Regulatory Element-binding Protein (SREBP)-1c by Posttranscriptional Down-regulation of Insig-2A and Its Dissociation from SREBP Cleavage-activating Protein (SCAP)·SREBP-1c ComplexJournal of Biological Chemistry, 2009
- Gp78, a Membrane-Anchored Ubiquitin Ligase, Associates with Insig-1 and Couples Sterol-Regulated Ubiquitination to Degradation of HMG CoA ReductaseMolecular Cell, 2005
- Structure of the Sec23/24–Sar1 pre-budding complex of the COPII vesicle coatNature, 2002